Tag Archives: PCAWG: Pan-Cancer Analysis of Whole Genomes

Chief Medical Officer’s Generation Genome Report (BBC News / Department of Health / Bazian / Nature)

Posted on July 4, 2017 by Dementia and Elderly Care News

Summary The latest annual report from Professor Dame Sally Davies, the Chief Medical Officer (CMO) for England unveils a “genomic dream” vision, whereby whole genome screening (WGS) might soon become standard practice in the NHS, much like blood tests and biopsies. … Continue reading →

Posted in Acute Hospitals, BBC News, Commissioning, Community Care, Department of Health, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Standards, UK, Universal Interest | Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Annual Report of Chief Medical Officer 2016: Generation Genome, Bazian, Behind the Headlines, Cancer Diagnosis, Cancer Genetics, Cancer Genome Atlas (TCGA), Cancer Research, Chief Medical Officer: Professor Dame Sally Davies, Data Protection, Data Protection Procurement Rules and Competition Rules (Potential Barriers to Information Sharing), Data Protection Procurement Rules and Competition Rules (Potential Barriers to Integration), Data Protection Procurement Rules and Competition Rules (Potential Barriers to Partnership Working), Diagnosis of Rare Diseases, Early Screening, Economics of Sequencing, Four Ps of Personalised Medicine: Participatory Role for Patients, Four Ps of Personalised Medicine: Precise Diagnoses, Four Ps of Personalised Medicine: Prediction and Prevention of Disease, Four Ps of Personalised Medicine: Targeted and Personalised Interventions, Generation Genome: 8th Annual Report of Chief Medical Officer (2016), Genetic Testing, Genomic Data Environment, Genomic England, Genomic Information and Insurance, Genomic Medicine, Genomic Medicine Centres, Genomic Services, Genomic Technologies, Genomic Volunteers, Genomics, Genomics and Personalised Medicine, Genomics and Theraputics, Genomics England, Human Genome Project, Human Genome Project (HGP), ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, International Cancer Genome Consortium (ICGC), Low Prevalence Rare and Complex Diseases, National Genomics Board (Proposal), National Institute for Health Research (NIHR), Nature, NIHR BioResource Rare Diseases, NIHR Rare Diseases Translational Research Collaboration (RD-TRC), Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, Pan-Cancer Analysis of Whole Genomes Consortium, Pathogen Genomics, PCAWG Consortium, PCAWG Evolution and Heterogeneity Working Group, PCAWG: Pan-Cancer Analysis of Whole Genomes, Personalised Medicine, Personalised Medicine Strategy for the NHS, Personalised Medicine: Improving Outcomes, Personalised Prevention, Phenotypes, Phenotyping, Prevention, Prevention Agenda, Professor Dame Sally Davies, Screening, Social Contract for Genomics in the NHS, UK Genetic Testing Network (UKGTN), Whole Genome Screening (WGS), Whole Genome Sequencing, Whole Genome Sequencing (WGS), Whole Genome Sequencing and Imputation | Leave a comment

Tag Archives: PCAWG: Pan-Cancer Analysis of Whole Genomes

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites